ACHE and Alzheimer disease: Collectively, these data demonstrate that both CL-80 and ar-turmerone effectively counteract Aβ1-42-induced cholinergic impairment by reducing AChE hyperactivity and restoring synaptic ACh levels, supporting their potential neuroprotective efficacy in AD models.